Author + information
- Received August 22, 1991
- Revision received December 10, 1991
- Accepted January 6, 1992
- Published online June 1, 1992.
- Leslee Shaw, MA,
- Bernard R. Chaitman, MD, FACC,
- Thomas C. Hilton, MD,
- Karen Stocke, BS,
- Liwa T. Younis, MD, PhD,
- Dennis G. Caralis, MD, MPH, FACC,
- Barbara A. Kong, MD, FACC and
- D.Douglas Miller, MD, FACC∗
- ↵∗Address for reprints: D. Douglas Miller, MD, Saint Louis University Medical Center, Division of Cardiology, 3635 Vista Avenue at Grand Boulevard, P.O. Box 15250, Saint Louis, Missouri 63110-0250.
The prognostic value of intravenous dipyridamole myocardial perfusion imaging has not been studied in a large series of elderly patients. Patients ≥70 years of age with known or suspected coronary artery disease were evaluated to determine the predictive value of intravenous dipyridamole thallium-201 imaging for subsequent cardiac death or nonfatal myocardial infarction. Of the 348 patients, 207 were symptomatic and 141 were asymptomatic; 52% of the asymptomatic group had documented coronary artery disease. During 23 ± 15 months of follow-up, there were 52 cardiac deaths, 24 nonfatal myocardial infarctions and 42 revascularization procedures (percutaneous transluminal coronary angioplasty in 20; coronary artery bypass surgery in 22). Clinical univariate predictors of a cardiac event included previous myocardial infarction, congestive heart failure symptoms, hypercholesterolemia and diabetes (all p < 0.05).
The presence of a fixed, reversible or combined thallium-201 defect was significantly associated with the occurrence of cardiac death or myocardial infarction during follow-up (p < 0.05). Cardiac death or nonfatal myocardial infarction occurred in only 7 (5%) of 150 patients with a normal dipyridamole thallium-201 study (p < 0.001). Stepwise logistic regression analysis of clinical and radionuclide variables revealed that an abnormal (reversible or fixed) dipyridamole thallium-201 study was the single best predictor of cardiac events (relative risk 7.2, p < 0.001). As has been demonstrated in younger patients, previous myocardial infarction (relative risk 1.8, p < 0.001) and symptoms of congestive heart failure at presentation (relative risk 1.6, p = 0.02) were also significant independent clinical predictors of cardiac death or myocardial infarction.
Dipyridamole thallium-201 myocardial imaging is a powerful independent noninvasive technique for prognostication in the elderly, a group with limited exercise capacity, the potential for advanced coronary artery disease and a high risk for cardiac events.
☆ This study was supported in part by a grant from the Lichtenstein Foundation, Saint Louis.
- Received August 22, 1991.
- Revision received December 10, 1991.
- Accepted January 6, 1992.